New scan aims to spot spreading cancer earlier
NCT ID NCT07331532
Summary
This study is testing a new type of PET scan that uses a special tracer called 68Ga-PFA2. The goal is to see if this scan can better detect when cancer has spread (metastasized) in patients with lung, breast, or pancreatic tumors. Researchers will compare this new scan to the standard FDG-PET scan currently used. The study is enrolling 10 adult patients with confirmed lung cancer who are scheduled for a biopsy or surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXPLORING THE DIAGNOSTIC POTENTIAL OF 68GA-PFA2 PET IMAGING IN ANNEXIN A2-POSITIVE TUMORS, INCLUDING BREAST CANCER, LUNG CANCER, AND PANCREATIC CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Peking university first hospital nuclear medicine
RECRUITINGBeijing, Beijing Municipality, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.